Antibiotic Developments
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
SIRIO Launches New Consumer Health Gummies at CPHI Barcelona
Sirio Pharma will further expand its offering in the consumer health market, building on last month’s ‘pharma targeted’ softgel launch, with the introduction of a range of herbal gummies for trending consumer health categories. Read more
6 Oct 2023
ANL and SoundCell awarded grant for antibiotic sensitivity test
Applied Nanolayers BV (ANL) and SoundCell BV have received €275,000 R&D funding from Provincie Zuid-Holland to develop a prototype for SoundCell’s high throughput single-cell graphene antibiotic sensitivity test. Read more
27 Mar 2023
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
European Commission Approves Pfizer’s PREVENAR 20
Pfizer Inc have announced that the European Commission (EC) has granted marketing authorisation for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
ReciBioPharm and GeneVentiv Therapeutics to Partner
ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement with GeneVentiv Therapeutics to advance development of an Adeno-Associated Virus (AAV)-based universal gene therapy for haemophilia. Read more
18 Mar 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Tubulis Closes €128 Million Series B
Tubulis have announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
CryoLogyx Completes £500k Seed Funding Round
CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, have announced the close of its oversubscribed seed funding round. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
FDA Approves Bristol Myers Squibb’s Breyanzi
Bristol Myers Squibb have announced the U.S FDA has granted accelerated approval of Breyanzi (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25